Shock Wave Therapy Tested for Muscle Stiffness After Stroke
Tests shock wave therapy against usual care for muscle stiffness in adults after stroke.
Plain-language title generated from the registry record
Registry title: Efficacy of Shock Wave Therapy in Post-Stroke Muscle Spasticity Management
Key facts
- Where
- Oviedo, SpainSee the site
Where in Spain
- University of OviedoOviedo, SpainNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Oviedo
- Trial code
- NCT06815328
- Record updated
- 12 March 2025
- Original description
The goal of this clinical trial is to evaluate the efficacy and safety of shock wave therapy (SWT) in reducing muscle spasticity in patients who have suffered a stroke. The main questions it aims to answer are:Read full original descriptionShow less
Efficacy of Shock Wave Therapy in Patients with Muscle Spasticity After a Stroke
The goal of this clinical trial is to evaluate the efficacy and safety of shock wave therapy (SWT) in reducing muscle spasticity in patients who have suffered a stroke. The main questions it aims to answer are:
Does SWT reduce muscle tone and improve joint range of motion in post-stroke patients with spasticity? Does SWT improve the quality of life for these patients? What side effects, if any, occur during or after SWT? Researchers will compare SWT to conventional spasticity treatments to determine its effectiveness and potential advantages.
Participants will:
Undergo SWT sessions as part of their rehabilitation protocol over a period of 8 weeks.
Attend follow-up visits to assess muscle tone, joint mobility, and overall functional improvement.
Complete quality-of-life questionnaires to measure the therapy's impact on daily living.
"Inclusion Criteria":; Adults aged 18 years or older; Confirmed diagnosis of stroke (ischemic or hemorrhagic) at least 6 months prior to enrollment; Clinically diagnosed muscle spasticity, measured by the Modified Ashworth Scale (MAS), with a score of 0 to 3; Stable medical condition that permits participation in the intervention; No significant changes in spasticity-related treatment for at least 3 months prior to the study; Ability to provide written informed consent to participate in the study; Ability to attend weekly sessions and follow-up visits as required; "Exclusion Criteria":; Severe spasticity or contractures unresponsive to prior treatments; Contraindications to Shock Wave Therapy, including:; Local infections in the treatment area; Known or suspected malignancy near the treatment site; Severe bleeding disorders or anticoagulation therapy; Pregnancy; Neurological conditions other than stroke that could interfere with study outcomes (e.g., Parkinson's disease, multiple sclerosis); Recent treatments that might interfere with spasticity assessment, including:; Injections of botulinum toxin within the past 6 months; Recent surgery or other interventions targeting spasticity; Cognitive impairment or other conditions preventing the participant from following instructions or completing study tasks; Severe cardiovascular, renal, or hepatic disease that might complicate therapy or participation; Inability to commit to follow-up visits or complete the intervention protocol due to logistical, mobility, or health-related issues.